➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,927,710

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,927,710
Title:Substituted polycyclic carbamoylpyridone derivative
Abstract: This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.
Inventor(s): Akiyama; Toshiyuki (Osaka, JP), Takaya; Kenji (Osaka, JP), Kawai; Makoto (Osaka, JP), Taoda; Yoshiyuki (Osaka, JP), Mikamiyama; Minako (Osaka, JP), Morimoto; Kenji (Osaka, JP), Kageyama; Chika (Osaka, JP), Tomita; Kenji (Osaka, JP), Mikamiyama; Hidenori (Osaka, JP), Suzuki; Naoyuki (Osaka, JP)
Assignee: Shionogi & Co., Ltd. (Osaka, JP)
Application Number:13/378,334
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 8,927,710

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-001 Oct 24, 2018 RX Yes No   Start Trial   Start Trial Y   Start Trial
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-002 Oct 24, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,927,710

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2009-142166Jun 15, 2009
PCT Information
PCT FiledJune 14, 2010PCT Application Number:PCT/JP2010/060006
PCT Publication Date:December 23, 2010PCT Publication Number: WO2010/147068

International Family Members for US Patent 8,927,710

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 102482219   Start Trial
China 102803260   Start Trial
China 104151234   Start Trial
China 104230795   Start Trial
China 105037259   Start Trial
Denmark 2444400   Start Trial
European Patent Office 2412708   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.